nach oben

Archives of Osteoporosis

Erschienen in:

01.12.2021 | Review

Correlation of oxidative stress-related biomarkers with postmenopausal osteoporosis: a systematic review and meta-analysis

verfasst von: Fulong Zhao, Lijuan Guo, Xuefei Wang, Yakui Zhang

Erschienen in: Archives of Osteoporosis | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Summary

Oxidative stress (OS) is implicated in postmenopausal osteoporosis (PO). Results show an imbalance between antioxidative and oxidative markers in PO. Thus, monitoring of OS-related biomarkers and keeping balance between reactive oxygen species and antioxidant system are beneficial to the diagnosis and prognosis of PO.

Purpose

Oxidative stress (OS) has been implicated in postmenopausal osteoporosis (PO). However, the relations between OS-related markers and PO are controversial. This study aimed to quantitatively and comprehensively assess the roles of OS-related biomarkers in PO.

Methods

Relevant articles were retrieved from electronic databases. All OS-associated biomarkers with at least 2 independent study outcomes were meta-analyzed. The pooled standardized mean differences (SMD) with its 95% confidence intervals (CI) were presented.

Results

A total of 36 studies involving 16 OS-related biomarkers were investigated. The overall results showed that total oxidant status (TOS), superoxide dismutase (SOD), hydroperoxides (HY), paraoxonase (PON1), nitric oxide (NO), and homocysteine (Hcy) were not statistically different between the PO and control groups, whereas significantly increased levels of oxidative stress index (OSI), malondialdehyde (MDA), advanced oxidation protein products (AOPP), and vitamin B12, along with decreased total antioxidant status (TAS), total antioxidant power (TAP), catalase (CAT), glutathione peroxidase (GPx), uric acid (UA), and folate, were detected in the PO group. Subgroup analysis based on biological samples displayed significantly elevated NO in erythrocyte and Hcy in serum, along with decreased SOD in serum.

Conclusion

Monitoring of certain OS-related biomarkers might be beneficial to the diagnosis and prognosis of PO.

Nur mit Berechtigung zugänglich

(2000) Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement 17(1):1–45

Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S, Dawson-Hughes B (2014) The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res 29(11):2520–2526. https://doi.org/10.1002/jbmr.2269CrossRef

Carlo MB, Stefania G, Alessia D, Carlo C (2004) Oxygen, reactive oxygen species and tissue damage. Curr Pharm Des 10(14):1611–1626. https://doi.org/10.2174/1381612043384664CrossRef

Weitzmann MN, Pacifici R (2006) Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 116(5):1186–1194. https://doi.org/10.1172/JCI28550CrossRefPubMedPubMedCentral

Bai X-c LD, Bai J, Zheng H, Z-y K, X-m L, Luo S-q (2004) Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-κB. Biochem Biophys Res Commun 314(1):197–207. https://doi.org/10.1016/j.bbrc.2003.12.073CrossRefPubMed

Lean JM, Davies JT, Fuller K, Jagger CJ, Kirstein B, Partington GA, Urry ZL, Chambers TJ (2003) A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 112(6):915–923. https://doi.org/10.1172/JCI18859CrossRefPubMedPubMedCentral

Lean JM, Jagger CJ, Kirstein B, Fuller K, Chambers TJ (2005) Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology 146(2):728–735. https://doi.org/10.1210/en.2004-1021CrossRefPubMed

Yang S, Ries WL, Key LL Jr (1998) Nicotinamide adenine dinucleotide phosphate oxidase in the formation of superoxide in osteoclasts. Calcif Tissue Int 63(4):346–350. https://doi.org/10.1007/s002239900538CrossRefPubMed

Sheweita SA, Khoshhal KI (2007) Calcium metabolism and oxidative stress in bone fractures: role of antioxidants. Curr Drug Metab 8(5):519–525. https://doi.org/10.2174/138920007780866852CrossRefPubMed

10.

Voss P, Siems W (2006) Clinical oxidation parameters of aging. Free Radic Res 40(12):1339–1349. https://doi.org/10.1080/10715760600953859CrossRefPubMed

11.

Surapaneni KM, Venkataramana G (2007) Status of lipid peroxidation, glutathione, ascorbic acid, vitamin E and antioxidant enzymes in patients with osteoarthritis. Indian J Med Sci 61(1):9–14. https://doi.org/10.4103/0019-5359.29592CrossRefPubMed

12.

Zhang YB, Zhong ZM, Hou G, Jiang H, Chen JT (2011) Involvement of oxidative stress in age-related bone loss. J Surg Res 169(1):e37–e42. https://doi.org/10.1016/j.jss.2011.02.033CrossRefPubMed

13.

van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350(20):2033–2041. https://doi.org/10.1056/NEJMoa032546CrossRefPubMed

14.

McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350(20):2042–2049. https://doi.org/10.1056/NEJMoa032739CrossRefPubMed

15.

Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A (2006) Biomarkers of oxidative damage in human disease. Clin Chem 52(4):601–623. https://doi.org/10.1373/clinchem.2005.061408CrossRefPubMed

16.

Altindag O, Erel O, Soran N, Celik H, Selek S (2008) Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol Int 28(4):317–321. https://doi.org/10.1007/s00296-007-0452-0CrossRefPubMed

17.

Wells G, Shea B, O'Connell J (2014) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute Web site 7

18.

Rostom A, Dubé C, Cranney A, Saloojee N, Sy R, Garritty C, Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, McNeil J, Moher D, Mack D, Patel D (2004) Celiac Disease. Rockville (MD): Agency for Healthcare Research and Quality (US); (Evidence Reports/Technology Assessments, No. 104.) Appendix D. Quality Assessment Forms. Available from: https://www.ncbi.nlm.nih.gov/books/NBK35156/

19.

Badr S, Badr EAE, Hammouda GE, Hadhoud M, Soliman SG, Pandey D (2008) Oxidative stress and some antioxidant parameters in postmenopausal osteoporotic women with fractures. A case study. Turk J Geriatr 11:174–180

20.

Bahtiri E, Islami H, Rexhepi S, Qorraj-Bytyqi H, Thaçi K, Thaçi S, Karakulak C, Hoxha R (2015) Relationship of homocysteine levels with lumbar spine and femur neck BMD in postmenopausal women. Acta Reumatol Port 40(4):355–362PubMed

21.

Bailey RL, Looker AC, Lu Z, Fan R, Eicher-Miller HA, Fakhouri TH, Gahche JJ, Weaver CM, Mills JL (2015) B-vitamin status and bone mineral density and risk of lumbar osteoporosis in older females in the United States. Am J Clin Nutr 102(3):687–694. https://doi.org/10.3945/ajcn.115.108787CrossRefPubMedPubMedCentral

22.

Baines M, Kredan MB, Usher J, Davison A, Higgins G, Taylor W, West C, Fraser WD, Ranganath LR (2007) The association of homocysteine and its determinants MTHFR genotype, folate, vitamin B12 and vitamin B6 with bone mineral density in postmenopausal British women. Bone 40(3):730–736. https://doi.org/10.1016/j.bone.2006.10.008CrossRefPubMed

23.

Başkol G, Demir H, Banu Ç, Mevlüt B, Kocer D (2007) Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with osteoporosis. Erciyes Med J 29(4):268–273

24.

Behfar A, Sadeghi N, Oveisi MR, Jannat B, Hajimahmoodi M, Jamshidi A, Behzad M, Rastegary P (2008) The plasma antioxidant activity of superoxide dismutase enzyme in osteoporosis. Acta Med Iran 46(6):441–446

25.

Beyazit F, Pek E (2018) Effects of vitamin B(12), folate, uric acid, and serum biomarkers of inflammation on bone mineral density in postmenopausal women. Przeglad Menopauzalny 17(2):69–76. https://doi.org/10.5114/pm.2018.77305CrossRefPubMedPubMedCentral

26.

Bozkurt N, Erdem M, Yılmaz E, Erdem A, Biri A, Kubatova A, Bozkurt M (2009) The relationship of homocyteine, B12 and folic acid with the bone mineral density of the femur and lumbar spine in Turkish postmenopausal women. Arch Gynecol Obstet 280(3):381–387. https://doi.org/10.1007/s00404-009-0936-0CrossRefPubMed

27.

Bucciarelli P, Martini G, Martinelli I, Ceccarelli E, Gennari L, Bader R, Valenti R, Franci B, Nuti R, Mannucci PM (2010) The relationship between plasma homocysteine levels and bone mineral density in post-menopausal women. Eur J Intern Med 21(4):301–305. https://doi.org/10.1016/j.ejim.2010.03.017CrossRefPubMed

28.

Cagnacci A, Baldassari F, Rivolta G, Arangino S, Volpe A (2003) Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. Bone 33(6):956–959. https://doi.org/10.1016/j.bone.2003.07.001CrossRefPubMed

29.

Cervellati C, Bonaccorsi G, Cremonini E, Bergamini CM, Patella A, Castaldini C, Ferrazzini S, Capatti A, Picarelli V, Pansini FS, Massari L (2013) Bone mass density selectively correlates with serum markers of oxidative damage in post-menopausal women. Clin Chem Lab Med 51(2):333. https://doi.org/10.1515/cclm-2012-0095CrossRefPubMed

30.

Cervellati C, Bonaccorsi G, Cremonini E, Romani A, Fila E, Castaldini MC, Ferrazzini S, Giganti M, Massari L (2014) Oxidative stress and bone resorption interplay as a possible trigger for postmenopausal osteoporosis. Biomed Res Int 2014:569563–569568. https://doi.org/10.1155/2014/569563CrossRefPubMedPubMedCentral

31.

Daswani B, Gavali S, Desai M, Patil A, Khatkhatay MI (2016) Serum levels of phosphorylated heat shock protein 27 (pHSP27) are associated with bone mineral density in pre- & postmenopausal women: a pilot study. Indian J Med Res 143(3):288–296. https://doi.org/10.4103/0971-5916.182618CrossRefPubMedPubMedCentral

32.

Dikker O, Sahin M, Atar S, Bekpinar S (2018) Examination of oxidative stress markers in women with postmenopausal osteoporosis. Turk Osteoporoz Dergisi 24(1):15–20. https://doi.org/10.4274/tod.71501CrossRef

33.

Halıloglu B, Aksungar FB, Ilter E, Peker H, Akın FT, Ozekıcı U (2010) Relationship between bone mineral density, bone turnover markers and homocysteine, folate and vitamin B12 levels in postmenopausal women. Arch Gynecol Obstet 281(4):663–668. https://doi.org/10.1007/s00404-009-1297-4CrossRefPubMed

34.

Han W, Bai X, Wang N, Han L, Sun X, Chen X (2017) Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population. Arch Osteoporos 12(1):50. https://doi.org/10.1007/s11657-017-0345-0CrossRefPubMed

35.

Kakehasi AM, Carvalho AV, Maksud FA, Barbosa AJ (2012) Serum levels of vitamin B12 are not related to low bone mineral density in postmenopausal Brazilian women. Rev Bras Reumatol 52(6):863–869CrossRef

36.

Lin YF, Cao YF, Xin BZ, Chen WM (2006) Correlation between reactive oxygen species and bone matrix in postmenopausal women. Chin J Clin Rehabil 10:110–112

37.

S-z L, Tian L-f XP, G-h Z, Zheng F, Tian J, Ning Q-L, Zhu B-F, Lu S-M, Yan H (2011) Analysis of correlation between blood biochemical indicators and bone mineral density of post-menopausal women. Mol Biol Rep 38(2):939–948. https://doi.org/10.1007/s11033-010-0187-yCrossRef

38.

Madenci E, Güçbey S, Koca I, İbas E, Çiçek H (2014) Serum total oxıdatıve and antıoxıdatıve status ın patıents wıth postmenopausal osteoporosis. Nobel Med 11:83–86

39.

Maggio D, Barabani M, Pierandrei M, Polidori MC, Catani M, Mecocci P, Senin U, Pacifici R, Cherubini A (2003) Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 88(4):1523–1527. https://doi.org/10.1210/jc.2002-021496CrossRefPubMed

40.

Mittal M, Verma R, Mishra A, Singh A, Kumar V, Sawlani KK, Ahmad MK, Mishra P, Gaur R (2018) Relation of bone mineral density with homocysteine and cathepsin K levels in postmenopausal women. Indian J Endocrinol Metab 22(2):261–266. https://doi.org/10.4103/ijem.IJEM_575_17CrossRefPubMedPubMedCentral

41.

Ouzzif Z, Oumghar K, Sbai K, Mounach A, Derouiche EM, El Maghraoui A (2012) Relation of plasma total homocysteine, folate and vitamin B12 levels to bone mineral density in Moroccan healthy postmenopausal women. Rheumatol Int 32(1):123–128. https://doi.org/10.1007/s00296-010-1551-xCrossRefPubMed

42.

Ozgocmen S, Kaya H, Fadillioglu E, Aydogan R, Yilmaz Z (2007) Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Mol Cell Biochem 295(1):45–52. https://doi.org/10.1007/s11010-006-9270-zCrossRefPubMed

43.

Ozgocmen S, Kaya H, Fadillioglu E, Yilmaz Z (2007) Effects of Calcitonin, Risedronate, and Raloxifene on Erythrocyte Antioxidant Enzyme Activity, Lipid Peroxidation, and Nitric Oxide in Postmenopausal Osteoporosis. Arch Med Res 38(2):196–205. https://doi.org/10.1016/j.arcmed.2006.09.010CrossRefPubMed

44.

Sahin G, Guler H, Sezgin M, Incel NA, Polat G (2006) The effect of circulating nitric oxide level on axial bone mineral density in postmenopausal Turkish women with rheumatoid arthritis: a preliminary report. Rheumatol Int 26(9):805–809. https://doi.org/10.1007/s00296-005-0091-2CrossRefPubMed

45.

Sendur OF, Turan Y, Tastaban E, Serter M (2009) Antioxidant status in patients with osteoporosis: A controlled study. Joint Bone Spine 76(5):514–518. https://doi.org/10.1016/j.jbspin.2009.02.005CrossRefPubMed

46.

Sharma T, Islam N, Ahmad J, Akhtar N, Beg M (2015) Correlation between bone mineral density and oxidative stress in postmenopausal women. Indian J Endocrinol Metab 19(4):491–497. https://doi.org/10.4103/2230-8210.159053CrossRefPubMedPubMedCentral

47.

Tariq S, Tariq S, Lone KP (2018) Interplay of vitamin D, vitamin B(12), homocysteine and bone mineral density in postmenopausal females. Health Care Women Int 39(12):1340–1349. https://doi.org/10.1080/07399332.2018.1444042CrossRefPubMed

48.

Toptaş B, Kurt Ö, Aydoğan HY, Yaylim I, Zeybek Ü, Can A, Agachan B, Uyar M, Özyavuz MK, İsbir T (2013) Investigation of the common paraoxonase 1 variants with paraoxonase activity on bone fragility in Turkish patients. Mol Biol Rep 40(11):6519–6524. https://doi.org/10.1007/s11033-013-2770-5CrossRefPubMed

49.

Verit FF, Celik H, Yazgan P, Erel O, Geyikli I (2006) Paraoxonase-1 activity as a marker of atherosclerosis is not associated with low bone mineral density in healthy postmenopausal women. Arch Gynecol Obstet 275(5):353. https://doi.org/10.1007/s00404-006-0260-xCrossRefPubMed

50.

Wu Q, Zhong Z-M, Pan Y, Zeng J-H, Zheng S, Zhu S-Y, Chen J-T (2015) Advanced Oxidation Protein Products as a Novel Marker of Oxidative Stress in Postmenopausal Osteoporosis. Med Sci Monit 21:2428–2432. https://doi.org/10.12659/MSM.894347CrossRefPubMedPubMedCentral

51.

Yilmaz N, Kepkep N, Ciçek HK, Celik A, Meram I (2006) Relation of parity and homocysteine to bone mineral density of postmenopausal women. Clin Lab 52(1-2):49–56PubMed

52.

Yilmaz N, Eren E (2009) Homocysteine oxidative stress and relation to bone mineral density in post-menopausal osteoporosis. Aging Clin Exp Res 21(4-5):353–357. https://doi.org/10.1007/bf03324927CrossRefPubMed

53.

Yousefzadeh G, Larijani B, Mohammadirad A, Heshmat R, Dehghan G, Rahimi R, Abdollahi M (2006) Determination of Oxidative Stress Status and Concentration of TGF-β1 in the Blood and Saliva of Osteoporotic Subjects. Ann N Y Acad Sci 1091(1):142–150. https://doi.org/10.1196/annals.1378.062CrossRefPubMed

54.

Zinnuroglu M, Dincel AS, Kosova F, Sepici V, Karatas GK (2012) Prospective evaluation of free radicals and antioxidant activity following 6-month risedronate treatment in patients with postmenopausal osteoporosis. Rheumatol Int 32(4):875–880. https://doi.org/10.1007/s00296-010-1708-7CrossRefPubMed

55.

Sontakke AN, Tare RS (2002) A duality in the roles of reactive oxygen species with respect to bone metabolism. Clin Chim Acta 318(1):145–148. https://doi.org/10.1016/S0009-8981(01)00766-5CrossRefPubMed

56.

Garrett IR, Boyce BF, Oreffo RO, Bonewald L, Poser J, Mundy GR (1990) Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 85(3):632–639. https://doi.org/10.1172/JCI114485CrossRefPubMedPubMedCentral

57.

Sacheck JM, Blumberg JB (2001) Role of vitamin E and oxidative stress in exercise. Nutrition 17(10):809–814. https://doi.org/10.1016/S0899-9007(01)00639-6CrossRefPubMed

58.

Zhou Q, Zhu L, Zhang D, Li N, Li Q, Dai P, Mao Y, Li X, Ma J, Huang S (2016) Oxidative Stress-Related Biomarkers in Postmenopausal Osteoporosis: A Systematic Review and Meta-Analyses. Dis Markers 2016:7067984–7067984. https://doi.org/10.1155/2016/7067984CrossRefPubMedPubMedCentral

59.

Chen F, Wang Y, Guo Y, Wang J, Yang A, Lv Q, Liu Y, Ma G, Liu Y, Wang D (2019) Specific higher levels of serum uric acid might have a protective effect on bone mineral density within a Chinese population over 60 years old: a cross-sectional study from northeast China. Clin Interv Aging 14:1065–1073. https://doi.org/10.2147/CIA.S186500CrossRefPubMedPubMedCentral

60.

Ishii S, Miyao M, Mizuno Y, Tanaka-Ishikawa M, Akishita M, Ouchi Y (2014) Association between serum uric acid and lumbar spine bone mineral density in peri- and postmenopausal Japanese women. Osteoporos Int 25(3):1099–1105. https://doi.org/10.1007/s00198-013-2571-7CrossRefPubMed

61.

Makovey J, Macara M, Chen JS, Hayward CS, March L, Seibel MJ, Sambrook PN (2013) Serum uric acid plays a protective role for bone loss in periand postmenopausal women: A longitudinal study. Bone 52(1):400–406. https://doi.org/10.1016/j.bone.2012.10.025CrossRefPubMed

62.

Zhang H, Tao X, Wu J (2014) Association of homocysteine, vitamin B12, and folate with bone mineral density in postmenopausal women: a meta-analysis. Arch Gynecol Obstet 289(5):1003–1009. https://doi.org/10.1007/s00404-013-3075-6CrossRefPubMed

63.

Cagnacci A, Bagni B, Zini A, Cannoletta M, Generali M, Volpe A (2008) Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. Bone 42(2):314–320. https://doi.org/10.1016/j.bone.2007.10.022CrossRefPubMed

64.

Herrmann M, Peter Schmidt J, Umanskaya N, Wagner A, Taban-Shomal O, Widmann T, Colaianni G, Wildemann B, Herrmann W (2007) The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies in osteoporosis: a systematic review. Clin Chem Lab Med 45(12):1621–1632. https://doi.org/10.1515/cclm.2007.362CrossRefPubMed

65.

Dhonukshe-Rutten RAM, Lips M, de Jong N, Chin A, Paw MJM, Hiddink GJ, van Dusseldorp M, de Groot LCPGM, van Staveren WA (2003) Vitamin B-12 Status Is Associated with Bone Mineral Content and Bone Mineral Density in Frail Elderly Women but Not in Men. J Nutr 133(3):801–807. https://doi.org/10.1093/jn/133.3.801CrossRefPubMed

Titel: Correlation of oxidative stress-related biomarkers with postmenopausal osteoporosis: a systematic review and meta-analysis
verfasst von: Fulong Zhao
Lijuan Guo
Xuefei Wang
Yakui Zhang
Publikationsdatum: 01.12.2021
Verlag: Springer London
Erschienen in: Archives of Osteoporosis / Ausgabe 1/2021
Print ISSN: 1862-3522
Elektronische ISSN: 1862-3514
DOI: https://doi.org/10.1007/s11657-020-00854-w

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Summary

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Hip fracture and mortality: study of specific causes of death and risk factors

How does proximal femur BMD of healthy Irish adults compare to NHANES III? Results of the DXA-HIP Project

Age- and sex-specific concentrations of bone remodeling markers in healthy Indian adults with and without vitamin D deficiency

Correction to: Osteoporosis knowledge, attitudes, and practices among female Princess Nourah University students in Riyadh, Saudi Arabia

Endurance running prevents the age-related decline of calcaneal bone stiffness

Change in vertebral strength and bone mineral density in men and women over the year post-hip fracture: a subgroup analysis